Results 1 to 10 of about 77,137 (161)
Association of mast cells with helicobacter pylori infection in the antral mucosa
Journal of Pathology of Nepal, 2011 Background: Helicobacter pylori infection is associated with mixed inflammatory cell infiltrate consisting of neutrophils, eosinophils, lymphocytes and plasma cells.
SR KC, GL Amatya
doaj +3 more sources
The evolution of SARS-CoV-2 and the COVID-19 pandemic [PDF]
PeerJ, 2023 Scientists have made great efforts to understand the evolution of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) to provide crucial information to public health experts on strategies to control this viral pathogen.
Yuanfang Si +10 more
doaj +2 more sources
Molecular docking of a set of flavonoid compounds with Helicobacter pylori virulence factors CagA and VacA [PDF]
Journal of HerbMed Pharmacology, 2020 Introduction: Cytotoxin associated gene A (CagA) and vacuolating cytotoxin A (VacA) proteins are the main Helicobacter pylori virulence factors. These toxins are associated with severe gastric diseases.
Mohamed Reda Jouimyi +7 more
doaj +1 more source
AORN Journal, 1997 Helicobacter pylori is a gram-negative bacterium which causes chronic gastritis and plays important roles in peptic ulcer disease, gastric carcinoma, and gastric lymphoma. H. pylori has been found in the stomachs of humans in all parts of the world. In developing countries, 70 to 90% of the population carries H. pylori.
B E, Dunn, H, Cohen, M J, Blaser
+6 more sources
Epigenetics and Helicobacter pylori [PDF]
International Journal of Molecular Sciences, 2022 Epigenetics regulates gene expression, cell type development during differentiation, and the cell response to environmental stimuli. To survive, bacteria need to evade the host immune response. Bacteria, including Helicobacter pylori (Hp), reach this target epigenetically, altering the chromatin of the host cells, in addition to several more approaches,
Capparelli R., Iannelli D.
openaire +3 more sources
Armeniaspirol A: a novel anti‐Helicobacter pylori agent
Microbial Biotechnology, 2022 Summary Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H.
Jia Jia +8 more
doaj +1 more source
Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment
Frontiers in Genetics, 2022 Gastric cancer (GC) is a highly fatal and common malignancy of the digestive system. Recent therapeutic advancements have significantly improved the clinical outcomes in GC, but due to the unavailability of suitable molecular targets, a large number of ...
Fazhan Li +17 more
doaj +1 more source
Clinical implications of lncRNA LINC-PINT in cancer
Frontiers in Molecular Biosciences, 2023 Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade.
Ihtisham Bukhari +6 more
doaj +1 more source
Anaesthesia, 1998 H pylori is now recognised as a treatable primary cause of both gastric ulcers and gastric adenocarcinoma. Most infections remain asymptomatic. Persons with signs and symptoms which correlate with potential infection with H pylori should be tested and, if positive, treated with a recognised triple antibiotic regimen.
G, Fisher +3 more
+10 more sources
Frontiers in Microbiology, 2022 BackgroundHelicobacter pylori (H. pylori) is an important pathogenic microorganism that causes gastric cancer, peptic ulcers and dyspepsia, and infects more than half of the world’s population. Eradicating H. pylori is the most effective means to prevent
Zishao Zhong +17 more
doaj +1 more source